Zimmer Biomet (ZBH) PT Raised to $105 at Bernstein SocGen Group

Bernstein SocGen Group analyst Lee Hambright raised the price target on Zimmer Biomet (NYSE: ZBH) to $105.00 (from $100.00) while maintaining a Market Perform rating.

The analyst commented: "We rate ZBH Market-Perform with a price target of $105 (previously $100) using a P/E multiple of 12.0x (up from11.5x) against our forward Q5-Q8 EPS of $8.76 (previously $8.66). The story is improving, and it could get better if the company can execute on its plan for steep growth acceleration in 2H25."

You May Also Be Interested In

• GLJ Research Downgrades Fluence Energy Inc. (FLNC) to Hold
• Deutsche Bank Upgrades Target Hospitality (TH) to Buy
• Rubrik Inc (RBRK) PT Raised to $120 at Oppenheimer; Sees Another 'Beat and Raise'